Healthcare
Monday, January 2, 2017
BRIEF-Actinogen Medical receives FDA approval to commence alzheimer's disease clinical trial
* FDA approval to commence alzheimer's disease clinical
trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment